Cancer Immunotherapy

When Will There Ever Be a Cure for HPV?

While the American people may not all agree on politics, religion or the benefits of a U.S.-Mexican border wall, there’s one thing that brings nearly a quarter of the population together: HPV. At present, 79 million Americans are infected with the Human Papilloma Virus (HPV), with another 14 million becoming infected every year. HPV is […]

Most Funded Synthetic Biology Companies in 2018

It’s that time of the year again when you start returning or re-gifting all of the plastic crap that got shoved under a slowly dying tree in that annual orgy of consumerism known as Christmas. It’s also the time of year when the media start to hit you with all those year-end lists of the […]

An Introduction to Cancer Immunotherapy Treatments

Of all the things that your doctor could tell you that might be a cause for alarm, hearing that you have late-stage cancer is probably one of the worst. We’ve all heard people talk about a “cure for cancer” when in fact there is no one single cure. However, things are starting to look up […]

Dr. Soon-Shiong’s CAR-T IPO NantKwest

In an article last year, we highlighted a very ambitious startup called Nanthealth which is looking to revolutionize healthcare. Perhaps the most compelling aspect of Nanthealth is their leader, a certain Dr. Patrick Soon-Shiong whose past achievements in building successful companies has made him the most wealthiest American in the healthcare industry today. Earlier this year, we […]

Investing in Cancer Immunotherapy Companies

In 2013, Goldman Sachs identified 8 disruptive technologies for investors to watch, among them 3D printing, LED Lighting and something called “cancer immunotherapy“. While this has been heavily followed by biotech investors in the past, the term is just now becoming more mainstream since Vice News published a special report on HBO last month titled […]

Argos Therapeutics Helps Kidney Cancer Patients Live Longer

Cancer immunotherapy is a treatment that uses a patient’s own immune cells to attack malignant cancer cells. The treatment involves the creation of antibodies that grab onto target proteins that normally prevent immune cells from attacking cancer. By blocking the activity of these proteins, the immune cell is free to fight the disease. Merck, Roche, GlaxoSmithKline, Bristol-Myers Squibb, and others are […]